Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A PRC2-Kdm5b axis sustains tumorigenicity of acute myeloid leukemia
Zhihong Ren, Arum Kim, Yu‐Ting Huang, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 9
Open Access | Times Cited: 24

Showing 24 citing articles:

Roles of H3K4 methylation in biology and disease
Hua Wang, Kristian Helin
Trends in Cell Biology (2024)
Open Access | Times Cited: 17
NAC, NAC, Knockin’ on Heaven's door: Interpreting the mechanism of action of N-acetylcysteine in tumor and immune cells
Balaraman Kalyanaraman
Redox Biology (2022) Vol. 57, pp. 102497-102497
Open Access | Times Cited: 61
The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia
Hannah Lawson, James P. Holt‐Martyn, Vilma Dembitz, et al.
Nature Cancer (2024) Vol. 5, Iss. 6, pp. 916-937
Open Access | Times Cited: 11
Biomolecular condensation of human IDRs initiates endogenous transcription via intrachromosomal looping or high-density promoter localization
Jing Li, Shizhe Liu, Sung Hwan Kim, et al.
Nucleic Acids Research (2025) Vol. 53, Iss. 4
Open Access | Times Cited: 1
Epigenetic modulators provide a path to understanding disease and therapeutic opportunity
M. Honer, Benjamin Ferman, Zach H. Gray, et al.
Genes & Development (2024) Vol. 38, Iss. 11-12, pp. 473-503
Open Access | Times Cited: 8
RNA sequestration in P-bodies sustains myeloid leukaemia
Srikanth Kodali, Ludovica Proietti, Gemma Valcárcel, et al.
Nature Cell Biology (2024) Vol. 26, Iss. 10, pp. 1745-1758
Closed Access | Times Cited: 8
Epigenetic therapies targeting histone lysine methylation: complex mechanisms and clinical challenges
Sarah Gold, Ali Shilatifard
Journal of Clinical Investigation (2024) Vol. 134, Iss. 20
Open Access | Times Cited: 5
Histone lysine demethylase KDM5B facilitates proliferation and suppresses apoptosis in human acute myeloid leukemia cells through the miR-140-3p/BCL2 axis
Jiaojuan Huang, Shuiling Jin, Rongqun Guo, et al.
RNA (2024) Vol. 30, Iss. 4, pp. 435-447
Closed Access | Times Cited: 4
Diverse Functions of KDM5 in Cancer: Transcriptional Repressor or Activator?
Yasuyo Ohguchi, Hiroto Ohguchi
Cancers (2022) Vol. 14, Iss. 13, pp. 3270-3270
Open Access | Times Cited: 17
RNA in Stow, Leukemia on the Go: P-Bodies RNA Sequestration Drives Leukemogenesis
Alexandre A. Germanos, Sowndarya Muthukumar, Cristian Bellodi
Cellular Reprogramming (2025)
Closed Access
20 years of histone lysine demethylases: From discovery to the clinic and beyond
Zach H. Gray, M. Honer, Pooja Ghatalia, et al.
Cell (2025) Vol. 188, Iss. 7, pp. 1747-1783
Closed Access
NUP98 Rearrangements in AML: Molecular Mechanisms and Clinical Implications
Sagarajit Mohanty
Onco (2023) Vol. 3, Iss. 3, pp. 147-164
Open Access | Times Cited: 8
To Erase or Not to Erase: Non-Canonical Catalytic Functions and Non-Catalytic Functions of Members of Histone Lysine Demethylase Families
Elena Di Nisio, Valeria Manzini, Valerio Licursi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6900-6900
Open Access | Times Cited: 2
Comprehensive analysis for cellular senescence-related immunogenic characteristics and immunotherapy prediction of acute myeloid leukemia
Yan Mao, Jinwen Xu, Xuejiao Xu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Leukemia aggressiveness is driven by chromatin remodeling and expression changes of core regulators
Gracia Bonilla, A. Morris, Sharmistha Kundu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Polycomb Repressive Complex 2 in Oncology
Yiran Guo, Yao Yu, Gang Greg Wang
Cancer treatment and research (2023), pp. 273-320
Closed Access | Times Cited: 2
A novel gene fusion RUNX1/ZNF423 promotes leukemic relapse of NUP98-rearranged AML
Wenxin Du, Zhimei Xia, Zebin Luo, et al.
Leukemia (2023) Vol. 37, Iss. 11, pp. 2286-2291
Closed Access | Times Cited: 2
Histone demethylase enzymes KDM5A and KDM5B modulate immune response by suppressing transcription of endogenous retroviral elements
Huadong Chen, Letitia Sarah, Daniela Pucciarelli, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
KDM5 Lysine Demethylases in Pathogenesis, from Basic Science Discovery to the Clinic
Shang‐Min Zhang, Jian Cao, Qin Yan
Advances in experimental medicine and biology (2023), pp. 113-137
Closed Access | Times Cited: 1
Establishment and validation of a gene mutation-based risk model for predicting prognosis and therapy response in acute myeloid leukemia
Yun Liu, Teng Li, Hongling Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 10, pp. e31249-e31249
Open Access
KDM5A/B contribute to HIV-1 latent infection and survival of HIV-1 infected cells
Tai-Wei Li, Youngmin Park, Emily G. Watters, et al.
Antiviral Research (2024) Vol. 228, pp. 105947-105947
Open Access
The epigenetic role of EZH2 in acute myeloid leukemia
Jinyong Fang, Jingcheng Zhang, Lujian Zhu, et al.
PeerJ (2024) Vol. 12, pp. e18656-e18656
Open Access
Awakening KDM5B to defeat leukemia
Lok-Hei Chan, Qin Yan
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 13
Open Access | Times Cited: 2
KDM5A/B promotes HIV-1 latency and KDM5 inhibitors promote HIV-1 lytic reactivation
Tai-Wei Li, Dawei Zhou, Zhenyu Wu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top